High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC

Journal of the American Society of Nephrology

Volumn 21, Issue 10, 2010, Pages 1667-1677

  Sun, Peng ^a   Lin, Dao Hong ^a   Yue, Peng ^a   Jiang, Houli ^a   Gotlinger, Katherine H ^a   Schwartzman, Michal L ^a   Falck, John R ^b   Goli, Mohan ^b   Wang, Wen Hui ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11,12 EPOXY 5,8,14 ICOSATRIENOIC ACID; ANGIOTENSIN 2 RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 EPOXYGENASE; DIHYDROXYICOSATRIENOIC ACID; EPITHELIAL SODIUM CHANNEL; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; UNCLASSIFIED DRUG; VALSARTAN; 11,12-EPOXY-5,8,14-EICOSATRIENOIC ACID; ANGIOTENSIN 1 RECEPTOR; ARACHIDONATE EPOXYGENASE; ARACHIDONIC ACID; DIHOMO GAMMA LINOLENIC ACID; POTASSIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REPRESSION; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PARENCHYMA; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PATCH CLAMP; POTASSIUM INTAKE; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; IN VITRO STUDY; METABOLISM; SPRAGUE DAWLEY RAT;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; EPITHELIAL SODIUM CHANNELS; EPOXIDE HYDROLASES; IN VITRO TECHNIQUES; KIDNEY TUBULES, COLLECTING; MALE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 77957860942     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2009111110     Document Type: Article

References (35)

1. Wei Y, Lin DH, Kemp R, Yaddanapudi GS, Nasjletti A, Falck JR, Wang WH: Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways. J Gen Physiol 124: 719-727, 2004
2. Nakagawa K, Holla VR, Wei Y, Wang WH, Gatica A, Wei S, Mei S, Miller CM, Cha DR, Price EJ, Zent R, Pozzi A, Breyer MD, Guan Y, Falck JR, Waterman MR, Capdevila JH: Salt sensitive hypertension is associated with a dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 116: 1696-1702, 2006
3. Sun P, Lin DH, Wang T, Babilonia E, Wang ZJ, Jin Y, Kemp R, Nasjletti A, Wang WH: Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC. Am J Physiol Renal Physiol 291: F1192-F1200, 2006
4. Hirt DL, Capdevila J, Falck JR, Breyer MD, Jacobson HR: Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. J Clin Invest 84: 1805-1812, 1989
5. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH: The kidney cytochrome P450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest 104: 751-760, 1999
6. Makita K, Takahashi K, Kerara A, Jacobson HR, Falck JR, Capdevila JH: Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 94: 2414-2420, 1994
7. Sun P, Liu W, Lin DH, Yue P, Kemp R, Satlin LM, Wang WH: Epoxyeicosatrienoic acid (EET) activates the Ca2+-dependent bid conductance K channel in the cortical collecting duct. J Am Soc Nephrol 20: 513-523, 2009
8. DeLozier TC, Tsao CC, Coulter SJ, Foley J, Bradbury JA, Zeldin DC, Goldstein JA: CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products. J Pharmacol Exp Ther 310: 845-854, 2004
9. Sealey JE, Clark I, Bull MB, Laragh JH: Potassium balance and the control of renin secretion. J Clin Invest 49: 2119-2127, 1970
10. Saikaley A, Bichet D, Kucharczyk J, Peterson LN: Neuroendocrine factors mediating polydipsia induced by dietary Na, Cl, and K depletion. Am J Physiol Regul Integr Comp Physiol 251: R1071-R1077, 1986
11. Ai D, Fu Y, Guo D, Tanaka H, Wang N, Tang C, Hammock BD, Shyy JY, Zhu Y: Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Proc Natl Acad Sci U S A 104: 9018-9023, 2007
12. Spector AA: Arachidonic acid cytochrome P450 epoxygenase pathway. J Lipid Res 50: S52-S56, 2009
13. Yu Z, Xu F, Huse LM, Morisseau C, Draper AJ, Newman JW, Parker C, Graham L, Engler MM, Hammock BD, Zeldin DC, Kroetz DL: Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res 87: 992-998, 2000
14. Jung O, Brandes RP, Kim IH, Schweda F, Schmidt R, Hammock BD, Busse R, Fleming I: Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension. Hypertension 45: 759-765, 2005
15. Roman RJ: P450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002
16. Escalante B, Erlij D, Falck JR, McGiff JC: Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science 251: 799-802, 1991
17. Ma YH, Schwartzman ML, Roman RJ: Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol 267: R579-R589, 1994
18. Wang WH, Lu M, Hebert SC: Cytochrome P-450 metabolites mediate extracellular Ca2+-induced inhibition of apical K channels in the TAL. Am J Physiol 270: C103-C111, 1996
19. Sakairi Y, Jacobson HR, Noland TD, Capdevila JH, Falck JR, Breyer MD: 5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. Am J Physiol 268: F931-F939, 1995
20. Imaoka S, Wedlund PJ, Ogawa H, Kimura S, Gonzalez FJ, Kim HY: Identification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase. J Pharmacol Exp Ther 267: 1012-1016, 1993
21. Muller DN, Theuer J, Shagdasuren E, Kaergel E, Honeck H, Park J-K, Markovic M, Barbosa-Sicard E, Dechend R, Wellner M, Kirsch T, Fiebeler A, Rothe M, Haller H, Luft FC, Schunck W-H: A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury. Am J Pathol 164: 521-532, 2004
22. Zhao X, Pollock DM, Zeldin DC, Imig JD: Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases. Hypertension 42: 775-780, 2003 (Pubitemid 37237324)
23. Elmarakby AA, Quigley JE, Pollock DM, Imig JD: Tumor necrosis factor alpha blockade increases renal Cyp2c23 expression and slows the progression of renal damage in salt-sensitive hypertension. Hypertension 47: 557-562, 2006
24. Ai D, Pang W, Li N, Xu M, Jones PD, Yang J, Zhang Y, Chiamvimonvat N, Shyy JY, Hammock BD, Zhu Y: Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy. Proc Natl Acad Sci U S A 106: 564-569, 2009
25. Lawton WJ, Fitz AE, Anderson EA, Sinkey CA, Coleman RA: Effect of dietary potassium on blood pressure, renal function, muscle sympathetic nerve activity, and forearm vascular resistance and flow in normotensive and borderline hypertensive humans. Circulation 81: 173-184, 1990
26. Smith SR, Klotman PE, Svetkey LP: Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension. J Am Soc Nephrol 2: 1302-1309, 1992
27. Bauer JH, Gauntner WC: Effect of potassium chloride on plasma renin activity and plasma aldosterone during sodium restriction in normal man. Kidney Int 15: 286-293, 1979
28. Jin L, Chao L, Chao J: Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR. Am J Physiol 276: F476-F484, 1999
29. Nasjletti A, Erman A, Cagen LM, Brooks DP, Crofton JT, Share L, Baer PG: High potassium intake selectively increases urinary PGF2 alpha excretion in the rat. Am J Physiol 248: F382-F388, 1985
30. Vallon V, Schroth J, Lang F, Kuhl D, Uchida S: Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1. Am J Physiol 297: F704-F712, 2009
31. Palmer LG, Antonian L, Frindt G: Regulation of apical K and Na channels and Na/K pumps in rat cortical collecting tubule by dietary K. J Gen Physiol 104: 693-710, 1994
32. Tian W, Salanova M, Xu H, Lindsley JN, Oyama TT, Anderson S, Bachmann S, Cohen DM: Renal expression of osmotically responsive cation channel TRPV4 is restricted to water-impermeant nephron segments. Am J Physiol Renal Physiol 287: F17-F24, 2004
33. Keseru B, Barbosa-Sicard E, Popp R, Fisslthaler B, Dietrich A, Gudermann T, Hammock BD, Falck JR, Weissmann N, Busse R, Fleming I: Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. FASEB J 22: 4306-4315, 2008
34. Vriens J, Owsianik G, Janssens A, Voets T, Nilius B: Determinants of 4 alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4. J Biol Chem 282: 12796-12803, 2007
35. Jiang H, Zhu AG, Mamczur M, Morisseau C, Hammock BD, Falck JR, McGiff JC: Hydrolysis of cis- and trans-epoxyeicosatrienoic acids by rat red blood cells. J Pharmacol Exp Ther 326: 330-337, 2008